Arkolith/Insider Trading/CRDF/Form 4

Pace Gary W

DirectorCardiff Oncology, Inc. (CRDF) · full profile →Form 4 · filed Dec 12, 2024
Net Buying
Open-Market Buys
$940K
Open-Market Sells
$0
Net Open-Market Flow
$940K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 11, 2024Buy(P)12K$2.60$30K1.1M
Dec 11, 2024Buy(P)350K$2.60$910K1.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-135767) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML